Use of bone morphogenetic proteins in sinus augmentation procedure.
Bone morphogenetic proteins (BMPs) have shown osteoinductive properties, and favorable regenerative responses to the graft materials containing BMPs have been reported. Maxillary sinus augmentation with placement of dental implants is a well-established technique for functional and aesthetic dental rehabilitation of partially or completely edentulous patients with severe maxillary atrophy, and attempts have been made to promote the bone formation using BMPs with different carriers in various animal models in sinus augmentation procedures.In this review, the summary was done on various carriers and the dosages for BMPs in sinus augmentation procedures.
Park
Jun-Beom
JB
Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 1664 McIntyre Drive, Ann Arbor, MI 48105, USA. jbassoonis@yahoo.co.kr
D000540:Alveolar Ridge Augmentation / Q000379:methods*; D000818:Animals; D001284:Atrophy; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D015921:Dental Implants; D004195:Disease Models, Animal; D004285:Dogs; D004337:Drug Carriers; D008437:Maxilla / Q000473:pathology / Q000601:surgery*; D008443:Maxillary Sinus / Q000601:surgery*; D010012:Osteogenesis / Q000187:drug effects / Q000502:physiology
D019485:Bone Morphogenetic Proteins; D015921:Dental Implants; D004337:Drug Carriers